Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.8.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2017
Dec. 31, 2016
Current assets    
Cash and cash equivalents $ 84,043 $ 158,779
Short-term deposits   22,694
Marketable securities - available-for-sale debt securities 124,218  
Accounts receivable, net of allowance for doubtful accounts of $0 and $0 206 1,480
Other current assets and prepaid expenses (including current portion of clinical materials) 21,716 15,798
Total current assets 230,183 198,751
Restricted cash 4,253 4,017
Clinical materials 4,695 2,580
Property, plant and equipment, net 40,679 27,899
Intangibles, net 1,337 1,268
Total assets 281,147 234,515
Current liabilities    
Accounts payable (including amounts due to related parties of $- and $326) 8,378 11,350
Accrued expenses and other accrued liabilities (including amounts due to related parties of $- and $39) 27,201 17,528
Deferred revenue 38,735 11,392
Total current liabilities 74,314 40,270
Deferred revenue, non-current   24,962
Other liabilities, non-current 3,849 3,141
Total liabilities 78,163 68,373
Contingencies and commitments - Note 9
Stockholders' equity    
Common stock - Ordinary shares par value GBP 0.001, 701,103,126 authorized and 562,119,334 issued and outstanding (2016: 574,711,900 authorized and 424,775,092 issued and outstanding) 854 683
Additional paid in capital 455,401 341,200
Accumulated other comprehensive loss (21,641) (14,249)
Accumulated deficit (231,630) (161,492)
Total stockholders' equity 202,984 166,142
Total liabilities and stockholders' equity $ 281,147 $ 234,515